Controversial Hydroxycut Legal Actions Have Recently Been Entered
On May 1, 2009, there was a recall of fourteen Hydroxycut diet-aid products springing from a number of reports that people using the products were developing serious liver issues and other health worries. Less than seven days later, on May 4, the 1st Hydroxycut class action court action was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Lawyer alleges company failure in informing the public about potential perils of the products. Naturally, it’s too shortly to know how the suit is going to turn out, but if the company had information which it did not reveal to customers, it should definitely be held accountable.
A class action court action is filed by a bunch of folk, all of whom have similar claims against a certain company. Filing a class action is just as effective, and a lot less expensive, than filing an individual suit. As a rule, filing a class action lawsuit won’t cost you anything unless there’s a settlement. At that point, the lawyer who handled the suit will take his costs from the compensation that got given and then assign the remaining funds to the plaintiffs in the case. Since this is the case, you will be ready to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is an example of the reasons that class action lawsuits have become so popular.
The first class action lawsuit against Iovate was filed in Canada where the company is located and represents all Canadian citizens who sustained health issues due to Hydroxycut products. The FDA recall took place in the U. S. where twenty-three cases of liver disorders and other health issues had been reported. Health Canada failed to receive any reports of liver damage caused by the diet products, but they did receive 17 reports concerning people who sustained respiration, neurological, heart, and gastrointestinal problems as a result of Canadians using the products.
The Hydroxycut Settlement Suit alleges the company sold the products without correctly informing the products without properly informing the health risks that they could exposing buyers to. The complaint states the company did not publish the information on the product labels stating that users could run the risk of liver and kidney damage as well as gastrointestinal, cardiovascular, respiratory, and neurological issues. The suit goes on to claim this was an obvious omission on the part of the company which purposely misled buyers concerning the security of the products.
